Literature DB >> 22100637

Devices for intradermal vaccination.

Elsa E Kis1, Gerhard Winter, Julia Myschik.   

Abstract

New insights in vaccine development, the need for safe, economic and efficient vaccine administration and the increasing mechanistic knowledge of immune responses induced by targeting the intradermal layers of the skin have all driven the engineering of devices for intradermal vaccination. In this review we highlight different delivery devices that make the epidermal and dermal layers of the skin accessible for vaccine administration. Depending on the device the desired vaccine can be applied either as a liquid formulation or as solid, powdered vaccine particles. The process of intradermal injection employs micron-sized needles that are inserted 1.5mm perpendicularly into the skin, and which inject approximately 100-200μl of a liquid vaccine formulation into the dermal skin layers. Tattoo devices, on the other hand, can be used to deliver liquid vaccine formulations into the dermal layer of the skin by the use of oscillating needles. Microneedle arrays are made of vaccine-coated solid microneedles or biodegradable microneedles. These are inserted into the dermal layers of the skin where either the vaccine coating is dissolved, or the microneedle itself dissolves in place. Jet-injectors operate by generating a high pressured stream, which flushes the liquid vaccine formulation into the deeper skin layers. Delivery devices using liquid vaccine formulations are advantageous, as established vaccine formulations can be used as provided without the need for reformulation. However, approaches that deliver vaccines in a solid form may also prove to be promising. One such method is the ballistic approach, in which solid vaccine particles or vaccine-coated gold particles are accelerated towards the skin by needle-free devices, so that the particles are deposited in the epidermal and dermal layers of the skin. These various delivery devices are explored in this review with regard to their delivery mechanism and ease of handling, their efficacy in clinical trials and their suitability for practical use.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Mesh:

Substances:

Year:  2011        PMID: 22100637     DOI: 10.1016/j.vaccine.2011.11.020

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  22 in total

Review 1.  Effect of vaccine administration modality on immunogenicity and efficacy.

Authors:  Lu Zhang; Wei Wang; Shixia Wang
Journal:  Expert Rev Vaccines       Date:  2015-08-27       Impact factor: 5.217

2.  Intradermal delivery of a fractional dose of influenza H7N9 split vaccine elicits protective immunity in mice and rats.

Authors:  Shanshan Zhou; Tianyu Ren; Hongjing Gu; Cheng Wang; Min Li; Zhongpeng Zhao; Li Xing; Liangyan Zhang; Yi Sun; Penghui Yang; Xiliang Wang
Journal:  Hum Vaccin Immunother       Date:  2018-02-12       Impact factor: 3.452

3.  Assessment of acceptability and usability of new delivery prototype device for intradermal vaccination in healthy subjects.

Authors:  Timothi J S Van Mulder; Stijn Verwulgen; Koen C L Beyers; Linda Scheelen; Monique M Elseviers; Pierre Van Damme; Vanessa Vankerckhoven
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

Review 4.  Intradermal vaccination using the novel microneedle device MicronJet600: Past, present, and future.

Authors:  Yotam Levin; Efrat Kochba; Ivan Hung; Richard Kenney
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

5.  Opportunities in an Evolving Pharmaceutical Development Landscape: Product Differentiation of Biopharmaceutical Drug Products.

Authors:  Andrea Allmendinger
Journal:  Pharm Res       Date:  2021-04-26       Impact factor: 4.200

6.  Enhancing the work of the Department of Health and Human Services national vaccine program in global immunization: recommendations of the National Vaccine Advisory Committee: approved by the National Vaccine Advisory Committee on September 12, 2013.

Authors: 
Journal:  Public Health Rep       Date:  2014       Impact factor: 2.792

7.  Minipigs as an animal model for dermal vaccine delivery.

Authors:  Ivo H J Ploemen; Hoang J H B Hirschberg; Heleen Kraan; Adrian Zeltner; Sandra van Kuijk; Danielle P K Lankveld; Michael Royals; Gideon F A Kersten; Jean-Pierre Amorij
Journal:  Comp Med       Date:  2014-02       Impact factor: 0.982

8.  A dose-ranging study in older adults to compare the safety and immunogenicity profiles of MF59®-adjuvanted and non-adjuvanted seasonal influenza vaccines following intradermal and intramuscular administration.

Authors:  Giovanni Della Cioppa; Uwe Nicolay; Kelly Lindert; Geert Leroux-Roels; Frédéric Clement; Flora Castellino; Cristina Galli; Nicola Groth; Yotam Levin; Giuseppe Del Giudice
Journal:  Hum Vaccin Immunother       Date:  2014-04-14       Impact factor: 3.452

Review 9.  Fluzone® intra-dermal (Intanza®/Istivac® Intra-dermal): An updated overview.

Authors:  Nicola Luigi Bragazzi; Andrea Orsi; Filippo Ansaldi; Roberto Gasparini; Giancarlo Icardi
Journal:  Hum Vaccin Immunother       Date:  2016-05-31       Impact factor: 3.452

Review 10.  Intradermal vaccination for infants and children.

Authors:  Akihiko Saitoh; Yuta Aizawa
Journal:  Hum Vaccin Immunother       Date:  2016-05-02       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.